265 related articles for article (PubMed ID: 19110628)
1. Design and production of retro- and lentiviral vectors for gene expression in hematopoietic cells.
Schambach A; Swaney WP; van der Loo JC
Methods Mol Biol; 2009; 506():191-205. PubMed ID: 19110628
[TBL] [Abstract][Full Text] [Related]
2. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
4. [The construction of lentivirus-mediated RNAi vector containing hTERT].
Zhao P; Fu Z; You YP; Wang CZ; Cheng YX; Lu XM; Lu A; Liu N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):27-31. PubMed ID: 18247299
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes.
Li MJ; Rossi JJ
Methods Enzymol; 2005; 392():218-26. PubMed ID: 15644184
[TBL] [Abstract][Full Text] [Related]
6. Knock-down of gene expression in hematopoietic cells.
Scherr M; Venturini L; Eder M
Methods Mol Biol; 2009; 506():207-19. PubMed ID: 19110629
[TBL] [Abstract][Full Text] [Related]
7. [Construction of a lentiviral vector for RNA interference of PRL-3 gene and its stable expression in SW480 cells].
Liu YH; Li JM; Zhou J; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):509-12. PubMed ID: 18495578
[TBL] [Abstract][Full Text] [Related]
8. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
Schambach A; Bohne J; Chandra S; Will E; Margison GP; Williams DA; Baum C
Mol Ther; 2006 Feb; 13(2):391-400. PubMed ID: 16226060
[TBL] [Abstract][Full Text] [Related]
9. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.
Persons DA; Mehaffey MG; Kaleko M; Nienhuis AW; Vanin EF
Blood Cells Mol Dis; 1998 Jun; 24(2):167-82. PubMed ID: 9642098
[TBL] [Abstract][Full Text] [Related]
10. [RelB silencing in mouse bone-marrow derived dendritic cells mediated by lentiviral vector].
Bao J; Wang Q; Zheng L; Qiu YR; Zeng FY; Yang CL; Huang XZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):857-60. PubMed ID: 18782515
[TBL] [Abstract][Full Text] [Related]
11. Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer.
Sheridan PL; Bodner M; Lynn A; Phuong TK; DePolo NJ; de la Vega DJ; O'Dea J; Nguyen K; McCormack JE; Driver DA; Townsend K; Ibañez CE; Sajjadi NC; Greengard JS; Moore MD; Respess J; Chang SM; Dubensky TW; Jolly DJ; Sauter SL
Mol Ther; 2000 Sep; 2(3):262-75. PubMed ID: 10985957
[TBL] [Abstract][Full Text] [Related]
12. Design and cloning of lentiviral vectors expressing small interfering RNAs.
Tiscornia G; Singer O; Verma IM
Nat Protoc; 2006; 1(1):234-40. PubMed ID: 17406238
[TBL] [Abstract][Full Text] [Related]
13. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
Neschadim A; McCart JA; Keating A; Medin JA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research.
Schambach A; Galla M; Modlich U; Will E; Chandra S; Reeves L; Colbert M; Williams DA; von Kalle C; Baum C
Exp Hematol; 2006 May; 34(5):588-92. PubMed ID: 16647564
[TBL] [Abstract][Full Text] [Related]
15. [A novel system for producing lentiviral vectors].
Ma Q; Li M; Dong WQ; Wu YS
Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):958-60. PubMed ID: 18051882
[TBL] [Abstract][Full Text] [Related]
16. [Construction of a lentiviral vector for RNA interference of human CDH22 gene and its gene silencing effect in SW480 cells].
Zhou J; Li JM; Yang FD; Liu YH; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):589-92. PubMed ID: 18495598
[TBL] [Abstract][Full Text] [Related]
17. Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells.
Moreno-Carranza B; Gentsch M; Stein S; Schambach A; Santilli G; Rudolf E; Ryser MF; Haria S; Thrasher AJ; Baum C; Brenner S; Grez M
Gene Ther; 2009 Jan; 16(1):111-8. PubMed ID: 18784749
[TBL] [Abstract][Full Text] [Related]
18. Real-time quantitative PCR for the design of lentiviral vector analytical assays.
Delenda C; Gaillard C
Gene Ther; 2005 Oct; 12 Suppl 1():S36-50. PubMed ID: 16231054
[TBL] [Abstract][Full Text] [Related]
19. Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors.
Schambach A; Galla M; Maetzig T; Loew R; Baum C
Mol Ther; 2007 Jun; 15(6):1167-73. PubMed ID: 17406345
[TBL] [Abstract][Full Text] [Related]
20. Retroviral vector-mediated gene expression in hematopoietic cells.
Baum C; Richters A; Ostertag W
Curr Opin Mol Ther; 1999 Oct; 1(5):605-12. PubMed ID: 11249667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
